Make WARTS, not cancer!

Abstract:

:The WARTS gene encodes a kinase that localizes to the mitotic apparatus of a dividing cell. Named WARTS after the growths that develop in the eyes of Drosophila in which the gene is deleted. WARTS is also implicated as a tumor suppressor in mice and humans. In this issue of Oncogene, Iida et al. describe experiments suggesting that, in addition to a role in regulating mitosis, WARTS functions to prevent further rounds of DNA synthesis and mitosis in tetraploid cells. As well as opening up new possibilities of exploring the as yet ill-defined mechanistic basis of the tetraploidy checkpoint, the involvement of a tumor-suppressor gene in this checkpoint supports its importance as a safeguard against the acquisition of genomic instability, a key event in the progression to cancer.

journal_name

Oncogene

journal_title

Oncogene

authors

Edwards KM,Münger K

doi

10.1038/sj.onc.1207686

subject

Has Abstract

pub_date

2004-07-08 00:00:00

pages

5263-5

issue

31

eissn

0950-9232

issn

1476-5594

pii

1207686

journal_volume

23

pub_type

评论,杂志文章

相关文献

ONCOGENE文献大全
  • Endogenous production of leukotriene D4 mediates autocrine survival and proliferation via CysLT1 receptor signalling in intestinal epithelial cells.

    abstract::The cysteinyl leukotriene1 (CysLT1) receptor (CysLT1R) enhances survival and proliferation of intestinal cells via distinct pathways. Here, we have demonstrated that there is significant endogenous production of CysLTs from both non-tumour- and tumour-derived intestinal epithelial cells. Treatment of two non-tumour ce...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209666

    authors: Paruchuri S,Mezhybovska M,Juhas M,Sjölander A

    更新日期:2006-10-26 00:00:00

  • Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.

    abstract::The microtubule-targeting antineoplastic agent, paclitaxel, is highly efficacious against a wide spectrum of human cancers. However, dose-limiting toxicity and development of drug resistance limit its clinical application. Development of novel strategies that overcome chemoresistance and sensitize cancer cells to pacl...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.23

    authors: Sreekanth CN,Bava SV,Sreekumar E,Anto RJ

    更新日期:2011-07-14 00:00:00

  • Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells.

    abstract::The retinoblastoma suppressor gene product Rb has been assigned a critical role in cell cycle regulation, the induction of differentiation, and inhibition of oncogenic transformation. Inheritance of a mutant RB allele in humans is responsible for bilateral retinoblastoma, a malignant tumor of the retina. Trilateral re...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205575

    authors: Vooijs M,te Riele H,van der Valk M,Berns A

    更新日期:2002-07-11 00:00:00

  • Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers.

    abstract::Silencing of the MLH1 gene by promoter hypermethylation is the mechanism underlying the microsatellite instability (MSI) phenotype in endometrial cancers. However, the profile of CpG methylation in a wide range of MLH1 promoters in endometrial cancers and in the normal endometrium is largely unknown. The present study...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206365

    authors: Kanaya T,Kyo S,Maida Y,Yatabe N,Tanaka M,Nakamura M,Inoue M

    更新日期:2003-04-17 00:00:00

  • Transcription elongation and eukaryotic gene regulation.

    abstract::Each step in the synthesis of functional transcript by RNA polymerase II provides a level at which gene expression can be regulated. Control over the elongation phase of transcription is a recognized regulatory mechanism in prokaryotes; however, only recently have examples of conditional transcription elongation block...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:

    authors: Spencer CA,Groudine M

    更新日期:1990-06-01 00:00:00

  • ETO-2, a new member of the ETO-family of nuclear proteins.

    abstract::The t(8;21) is associated with 12-15% of acute myelogenous leukemias of the M2 subtype. The translocation results in the fusion of two genes, AML1 (CBFA2) on chromosome 21 and ETO (MTG8) on chromosome 8. AML1 encodes a DNA binding factor; the ETO protein product is less well characterized, but is thought to be a trans...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202412

    authors: Davis JN,Williams BJ,Herron JT,Galiano FJ,Meyers S

    更新日期:1999-02-11 00:00:00

  • Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.

    abstract::Proteolytic cleavage of the extracellular domain of CD44 from the surface of cells has been observed recently in different cell types. In cell culture supernatants of human melanoma cell lines a 70 kDa soluble CD44 protein (solCD44) was detected at concentrations of 250-300 ng/ml. Protease inhibitor studies revealed t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204435

    authors: Ahrens T,Sleeman JP,Schempp CM,Howells N,Hofmann M,Ponta H,Herrlich P,Simon JC

    更新日期:2001-06-07 00:00:00

  • MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer.

    abstract::Migration and invasion inhibitory protein (MIIP) is recently identified as an inhibitor in tumor development. However, the regulatory mechanism and biological contributions of MIIP in pancreatic cancer (PC) have been not elucidated. In this study, we demonstrated a negative feedback of MIIP and hypoxia-induced factor-...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-017-0082-2

    authors: Niu Y,Jin Y,Deng SC,Deng SJ,Zhu S,Liu Y,Li X,He C,Liu ML,Zeng Z,Chen HY,Zhong JX,Ye Z,Wang CY,Zhao G

    更新日期:2018-03-01 00:00:00

  • The role of STATs in myeloid differentiation and leukemia.

    abstract::Myeloid differentiation is a highly regulated process governed by various cytokines, such as EPO, TPO, G-CSF, IL-3, IL-5 and GM-CSF. These cytokines act in part through activation of the STAT transcription factor family. In particular, various isoforms of STAT3 and STAT5 are activated during myeloid differentiation in...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1203479

    authors: Coffer PJ,Koenderman L,de Groot RP

    更新日期:2000-05-15 00:00:00

  • Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5'-RACE and LA - PCR analyses of biopsy samples.

    abstract::In order to elucidate the molecular mechanism(s) for BCL6 translocation, we identified translocational partner genes by subjecting clinical biopsy samples from patients with non-Hodgkin's lymphoma to 5'-rapid amplification of cDNA ends (5'-RACE). Sequence analysis of the 5'-RACE product revealed that the BCL6 gene was...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203293

    authors: Yoshida S,Kaneita Y,Aoki Y,Seto M,Mori S,Moriyama M

    更新日期:1999-12-23 00:00:00

  • Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition.

    abstract::Chronic inflammation has been associated with a variety of human cancers including prostate cancer. Interleukin-17 (IL-17) is a critical pro-inflammatory cytokine, which has been demonstrated to promote development of prostate cancer, colon cancer, skin cancer, breast cancer, lung cancer and pancreas cancer. IL-17 pro...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.240

    authors: Zhang Q,Liu S,Parajuli KR,Zhang W,Zhang K,Mo Z,Liu J,Chen Z,Yang S,Wang AR,Myers L,You Z

    更新日期:2017-02-02 00:00:00

  • U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.

    abstract::Upregulated gene 19 (U19)/ELL-associated factor 2 (Eaf2) is a potential human tumor suppressor that exhibits frequent allelic loss and downregulation in high-grade prostate cancer. U19/Eaf2, along with its homolog Eaf1, has been reported to regulate transcriptional elongation via interaction with the eleven-nineteen l...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210786

    authors: Xiao W,Zhang Q,Habermacher G,Yang X,Zhang AY,Cai X,Hahn J,Liu J,Pins M,Doglio L,Dhir R,Gingrich J,Wang Z

    更新日期:2008-03-06 00:00:00

  • p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.

    abstract::Activation of the TAL1 (or SCL) gene, originally identified through its involvement by a recurrent chromosomal translocation, is the most frequent gain-of-function mutation recognized in T-cell acute lymphoblastic leukemia (T-ALL). The TAL1 proteins contain a basic helix - loop - helix (bHLH) motif characteristic of a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202889

    authors: Huang S,Qiu Y,Stein RW,Brandt SJ

    更新日期:1999-09-02 00:00:00

  • Down-regulation of MHC class I antigens is not a general mechanism for the increased tumorigenicity caused by c-myc amplification.

    abstract::Previous studies have shown that increased expression of oncogenes from the myc-family can down-regulate the level of MHC class I antigens in tumor cells. This has suggested a mechanism by which amplification/overexpression of myc-genes may contribute to the malignancy development of certain tumors. Earlier published ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Dahllöf B

    更新日期:1990-03-01 00:00:00

  • TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.

    abstract::Early Growth Response 1 (EGR1) is a stress response transcription factor with multiple tumour suppressor roles in breast tissue, whose expression is often lost in breast cancers. We have previously shown that the breast cancer oncogene TBX2 (T-BOX2) interacts with EGR1 to co-repress EGR1-target genes including the bre...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0853-z

    authors: Crawford NT,McIntyre AJ,McCormick A,D'Costa ZC,Buckley NE,Mullan PB

    更新日期:2019-08-01 00:00:00

  • Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.

    abstract::Human telomerase is a unique reverse transcriptase that is expressed in multiple cancers, but not in the vast majority of normal cells. The enzyme is responsible for telomere protection and maintenance, and supports the proliferative immortality of cancer cells. Thus, it has been proposed that the specific inhibition ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205064

    authors: Herbert BS,Pongracz K,Shay JW,Gryaznov SM

    更新日期:2002-01-21 00:00:00

  • SUMOylation inhibits FOXM1 activity and delays mitotic transition.

    abstract::The forkhead box transcription factor FOXM1 is an essential effector of G2/M-phase transition, mitosis and the DNA damage response. As such, it is frequently deregulated during tumorigenesis. Here we report that FOXM1 is dynamically modified by SUMO1 but not by SUMO2/3 at multiple sites. We show that FOXM1 SUMOylation...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.546

    authors: Myatt SS,Kongsema M,Man CW,Kelly DJ,Gomes AR,Khongkow P,Karunarathna U,Zona S,Langer JK,Dunsby CW,Coombes RC,French PM,Brosens JJ,Lam EW

    更新日期:2014-08-21 00:00:00

  • Silencing expression of UO-44 (CUZD1) using small interfering RNA sensitizes human ovarian cancer cells to cisplatin in vitro.

    abstract::Ovarian cancer is currently the second leading cause of gynecological malignancy and cisplatin or cisplatin-based regimens have been the standard of care for the treatment of advance epithelial ovarian cancers. However, the efficacy of cisplatin treatment is often limited by the development of drug resistance either t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209836

    authors: Leong CT,Ong CK,Tay SK,Huynh H

    更新日期:2007-02-08 00:00:00

  • The regulation of translation by the 5' untranslated region of Xenopus c-myc I mRNA during early development.

    abstract::The translational efficiency of chloramphenicol acetyltransferase (CAT) mRNA containing 5' untranslated region (UTR) sequences of Xenopus c-myc I mRNA was examined in the Xenopus oocyte and early embryo. In contrast to their reduced translation in the oocyte, CAT mRNAs containing 5' UTR sequences located between the c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Lazarus P

    更新日期:1992-05-01 00:00:00

  • Analysis of a variant Max sequence expressed in Xenopus laevis.

    abstract::Max is a small helix-loop-helix protein which forms heterodimers with members of the Myc protein family. Myc/Max heterodimers exhibit sequence-specific DNA binding with much greater affinity than Myc homodimers. The Xenopus laevis homologue of Max, XMax, is shorter than the equivalent mammalian protein. This differenc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Tonissen KF,Krieg PA

    更新日期:1994-01-01 00:00:00

  • An siRNA screen identifies the GNAS locus as a driver in 20q amplified breast cancer.

    abstract::Poor-prognosis oestrogen receptor-positive breast cancer is characterised by the presence of high-level focal amplifications. We utilised a focused small interfering RNA screen in 14 breast cancer cell lines to define genes that were pathogenic in three genomic regions focally amplified in oestrogen receptor-positive ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.202

    authors: Garcia-Murillas I,Sharpe R,Pearson A,Campbell J,Natrajan R,Ashworth A,Turner NC

    更新日期:2014-05-08 00:00:00

  • A novel assay for the measurement of Raf-1 kinase activity.

    abstract::Raf-1 is a serine-threonine protein kinase that functions as a central component of the mitogen-activated protein kinase signal transduction pathway. Raf-1 activity is currently assayed in vitro by either measuring 32P incorporation into MEK, Raf-1's only characterized substrate, or by using the phosphorylated MEK to ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203862

    authors: Bondzi C,Grant S,Krystal GW

    更新日期:2000-10-12 00:00:00

  • Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.

    abstract::Experimental studies performed prior to 1990 led to the widely held belief that matrix metalloproteinases (MMPs) produced by cancer cells are of critical importance in tumor invasion and metastasis. Based on this evidence, the pharmaceutical industry produced several well tolerated, orally active MMP inhibitors (MMPIs...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1204097

    authors: Zucker S,Cao J,Chen WT

    更新日期:2000-12-27 00:00:00

  • The HIF1alpha-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element.

    abstract::The short isoform of single-minded 2 (SIM2s), a basic helix-loop-helix/PAS (bHLH/PAS) transcription factor, is upregulated in pancreatic and prostate tumours; however, a mechanistic role for SIM2s in these cancers is unknown. Microarray studies in prostate DU145 cells identified the pro-cell death gene, BNIP3 (Bcl-2/a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.228

    authors: Farrall AL,Whitelaw ML

    更新日期:2009-10-15 00:00:00

  • Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth.

    abstract::Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in malignant tumors and plays important roles in multiple aspects of cancer aggressiveness. Thus, targeting STAT3 promises to be an attractive strategy for the treatment of advanced metastatic tumors. Bisindolylmaleimide alkaloid (B...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-017-0076-0

    authors: Li X,Ma H,Li L,Chen Y,Sun X,Dong Z,Liu JY,Zhu W,Zhang JT

    更新日期:2018-05-01 00:00:00

  • The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization.

    abstract::ASPP1 and ASPP2 are both proteins that interact with p53 and enhance its ability to induce apoptosis by selectively elevating the expression of proapoptotic p53-responsive genes. iASPP(RAI) is a third member of the family that is the most conserved inhibitor of p53-mediated apoptosis. Here, we have described iASPP, a ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208088

    authors: Slee EA,Gillotin S,Bergamaschi D,Royer C,Llanos S,Ali S,Jin B,Trigiante G,Lu X

    更新日期:2004-12-02 00:00:00

  • Fas signaling promotes motility and metastasis through epithelial-mesenchymal transition in gastrointestinal cancer.

    abstract::Fas signaling was reported to participate in cell apoptosis. However, this pathway has also been shown to promote tumor cell motility, leading to the hypothesis that Fas signaling may induce epithelial-mesenchymal transition (EMT) to promote metastasis. The effects of Fas-ligand (FasL) treatment and inhibition of Fas ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.126

    authors: Zheng HX,Cai YD,Wang YD,Cui XB,Xie TT,Li WJ,Peng L,Zhang Y,Wang ZQ,Wang J,Jiang B

    更新日期:2013-02-28 00:00:00

  • Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters.

    abstract::An Ets-related E1A-F has been characterized as an enhancer-binding protein for the adenovirus E1A gene. Here we show, in transient expression assays, that E1A-F can activate three different subclasses of the matrix metalloproteinase gene promoters. Expressions of the chloramphenicol acetyltransferase (CAT) reporter ge...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Higashino F,Yoshida K,Noumi T,Seiki M,Fujinaga K

    更新日期:1995-04-06 00:00:00

  • The tumor suppressor WARTS activates the Omi / HtrA2-dependent pathway of cell death.

    abstract::Drosophila tumor suppressor WARTS (Wts) is an evolutionally conserved serine / threonine kinase and participates in a signaling complex that regulates both proliferation and apoptosis to ensure the proper size and shape of the fly. Human counterparts of this complex have been found to be frequently downregulated or mu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208682

    authors: Kuninaka S,Nomura M,Hirota T,Iida S,Hara T,Honda S,Kunitoku N,Sasayama T,Arima Y,Marumoto T,Koja K,Yonehara S,Saya H

    更新日期:2005-08-11 00:00:00

  • Alternative splicing in cancer: implications for biology and therapy.

    abstract::Alternative splicing has critical roles in normal development and can promote growth and survival in cancer. Aberrant splicing, the production of noncanonical and cancer-specific mRNA transcripts, can lead to loss-of-function in tumor suppressors or activation of oncogenes and cancer pathways. Emerging data suggest th...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2013.570

    authors: Chen J,Weiss WA

    更新日期:2015-01-02 00:00:00